Shifts in leadership, regulatory approvals, funding rounds, and commercialization strategies across the neurotech sector.
Neuralink
+5
May 24, 2026
•
5 min read
Meta's NeuralBench lands; NEO goes commercial
Neurotechnology
+6
May 9, 2026
2 min read
Neuralink, SetPoint, ARIA each bet differently
Clinical Trial News
+3
Apr 25, 2026
Plus €40.6M and a stealth exit
Closed-loop DBS
Apr 4, 2026
9 min read
Plus: living-neuron BCIs get a surgeon
Mar 8, 2026
16 min read
Science Corp. Leads the Pack
+7
Mar 1, 2026
12 min read
Plus: Japan's Stem Cell Gamble
Feb 8, 2026
7 min read
Poststroke outcomes, coverage signals
Feb 1, 2026
6 min read
Long-horizon signals emerge
Jan 17, 2026
Trials, Funding, FDA Signals
Dec 20, 2025
Regulation, reality, deployment
Dec 13, 2025
8 min read
BCIs, Stimulation, and Scale
Ethics & Policy
Nov 15, 2025
Decoding, biomarkers, and governance
Nov 8, 2025
Miniaturized BCIs & Global Neuro-Ethics
Nov 1, 2025
Clinical data, funding moves, and policy shifts
+4
Oct 25, 2025
Clinical Breakthroughs & Global Policy Shifts
Oct 18, 2025
Mechanisms, markets, and mental privacy
Oct 11, 2025
From Parkinson’s progress to pain-sharing tech
Oct 4, 2025
Clinical signals, market moves
Sep 27, 2025
Clinical, industry, and policy signals
Sep 13, 2025
Clinical wins & data rules
Sep 6, 2025
Privacy, Therapy & Beyond
Aug 23, 2025
Graphene control, FDA wins
Aug 16, 2025
BCI, industry moves, and neural privacy—this week’s signals.
Aug 9, 2025
From lab breakthroughs to policy battles shaping neurotech’s future.
Aug 2, 2025
From Stroke Recovery to Statewide Consent